ContractExecutive Termination Agreement • February 27th, 2009 • Millipore Corp /Ma • Laboratory analytical instruments • Massachusetts
Contract Type FiledFebruary 27th, 2009 Company Industry JurisdictionEXECUTIVE TERMINATION AGREEMENT, dated as of {Date} (the “Effective Date”), between MILLIPORE CORPORATION, a Massachusetts corporation with offices at 290 Concord Road, Billerica, Massachusetts 01821 (the “Company”), and {Name} (the “Executive”).
ContractExecutive Termination Agreement • March 16th, 2005 • Millipore Corp /Ma • Laboratory analytical instruments • Massachusetts
Contract Type FiledMarch 16th, 2005 Company Industry JurisdictionEXECUTIVE TERMINATION AGREEMENT, dated as of January 1, 2005, between MILLIPORE CORPORATION, a Massachusetts corporation with offices at 290 Concord Road, Billerica, Massachusetts 01821 (the “Company”), and Martin D. Madaus (the “Executive”).
EX-10.3 5 dex103.htm STANDARD EXECUTIVE AGREEMENT, AS AMMENDED EXECUTIVE TERMINATION AGREEMENTExecutive Termination Agreement • May 5th, 2020 • Massachusetts
Contract Type FiledMay 5th, 2020 JurisdictionAgreement between MILLIPORE CORPORATION, a Massachusetts corporation with offices at 290 Concord Road, Billerica, Massachusetts 01821 (“Millipore” or the “Company”) and (the “Executive”) dated .
EXECUTIVE TERMINATION AGREEMENT BETWEEN MYKROLIS CORPORATION AND PETER S. KIRLINExecutive Termination Agreement • May 6th, 2005 • Mykrolis Corp • Laboratory analytical instruments • Massachusetts
Contract Type FiledMay 6th, 2005 Company Industry JurisdictionThis Agreement (“Agreement”) between MYKROLIS CORPORATION, a Delaware corporation with offices at 129 Concord Road, Billerica, Massachusetts 01821 (“Mykrolis” or the “Company”) and Peter S. Kirlin (the “Executive”) dated March 19, 2005.
AGREEMENT --------- 1. Definitions -----------Executive Termination Agreement • March 13th, 2000 • Millipore Corp • Laboratory analytical instruments • Massachusetts
Contract Type FiledMarch 13th, 2000 Company Industry Jurisdiction
Executive Termination Agreement In The Event of Change or ControlExecutive Termination Agreement • April 1st, 2002 • Community Financial Group Inc • State commercial banks
Contract Type FiledApril 1st, 2002 Company IndustryThis Executive Termination Agreement In The Event of Change of Control (this "Agreement") entered into this 1st day of March, 2002, by and among COMMUNITY FINANCIAL GROUP, INC., a Tennessee corporation (the "Company"), THE BANK OF NASHVILLE, a banking corporation organized under the laws of the State of Tennessee (the "Bank"), and CONNELL BLAKE PARKS (the "Executive").
Executive Termination Agreement In The Event of Change of ControlExecutive Termination Agreement • April 1st, 2002 • Community Financial Group Inc • State commercial banks • Tennessee
Contract Type FiledApril 1st, 2002 Company Industry JurisdictionThis Executive Termination Agreement In the Event of Change of Control (this "Agreement") entered into this 1st day of March, 2002, by and among COMMUNITY FINANCIAL GROUP, INC., a Tennessee corporation (the "Company"), THE BANK OF NASHVILLE, a banking corporation organized under the laws of the State of Tennessee (the "Bank"), and JULIAN C. CORNETT (the "Executive").
EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASEExecutive Termination Agreement • November 10th, 2008 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Washington
Contract Type FiledNovember 10th, 2008 Company Industry JurisdictionThis EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASE (“Executive Termination Agreement” or “Agreement”) is entered into between Alan Fuhrman (“Executive”) and Sonus Pharmaceuticals, Inc. (to be renamed “OncoGenex Pharmaceuticals, Inc.”) (referred to herein as “Sonus” or “Employer”).
EX-10.2 2 dex102.htm EXECUTIVE TERMINATION LETTER AGREEMENT July 7, 2008 Delivered in Person Mr. Jean-Marc Pandraud Lexington, MA 02421 Dear Jean-Marc:Executive Termination Agreement • May 5th, 2020 • Massachusetts
Contract Type FiledMay 5th, 2020 JurisdictionYou have advised us of your decision to retire as an officer and employee of Entegris, Inc. and of its subsidiaries (the “Company”). The Company is willing to provide you with certain severance arrangements in connection with your retirement. The purpose of this letter is to confirm the agreement between you and the Company concerning your retirement and severance arrangements, as follows:
EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASEExecutive Termination Agreement • November 10th, 2008 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Washington
Contract Type FiledNovember 10th, 2008 Company Industry JurisdictionThis EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASE (“Executive Termination Agreement” or “Agreement”) is entered into between Michael A. Martino (“Executive”) and Sonus Pharmaceuticals, Inc. (to be renamed “OncoGenex Pharmaceuticals, Inc.”) (“Sonus” or “Employer”).
ContractExecutive Termination Agreement • May 12th, 2010 • Millipore Corp /Ma • Laboratory analytical instruments
Contract Type FiledMay 12th, 2010 Company IndustryAMENDMENT NO. 1, dated as of March {Date}, 2010 (this “Amendment”), to the Executive Termination Agreement (the “Executive Termination Agreement”) between Millipore Corporation (the “Company”) and {Name} (the “Executive”), dated as of {Date}.